Peripheral Nerve Repair Market Is Anticipated To Surpass Us$ 17.46 Billion By 2031: Data Analysis By Experts Growth Plus Reports
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 6.10 Billion |
| Market Size Value in 2031 | US$ 17.46 Billion |
| Growth Rate | CAGR of 12.4% from 2023 to 2031 |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023 to 2031 |
| Historical Year | 2021 |
| Segments Covered | Product, Application, End User, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Recent Development in the Global Peripheral Nerve Repair Market:
- In August 2022, The FDA approved Abbott's new Proclaim Plus spinal cord stimulation (SCS) device with FlexBurst360 therapy, the company reported. The FlexBurst360 procedure, the most recent iteration of Abbott's patented BurstDR stimulation, reduces pain in as many as six different areas of the trunk and limbs and enables programming that may be changed as a person's therapeutic requirements change.
Competitive Landscape
Following is a list of the top market players operating in the global market for peripheral nerve repair:
- Renerva LLC Medovent GmbH Abbott Laboratories Inc. Stryker Corporation Medtronic Plc Toyobo Co., Ltd.
Market Drivers and Restraints:
The global peripheral nerve repair market revenue is driven by the high frequency of nerve injuries, the growing interest in neuromodulation and neurostimulation technology, the aging population, and rising government funding for neurological disease research. Furthermore, one of the key aspects impacting the market for nerve repair and regeneration is the rise in neurological and epidemiological issues.
Market Segmentation:
Segmentation By Product
Based on product, the global peripheral nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. Due to the rising need for non-invasive therapies and new technologies being created, the neurostimulation and neuromodulation devices segment accounts for the largest market revenue share.
Segmentation By Application
Based on the application, the global peripheral nerve repair market is segmented into direct nerve repair, stem cell therapy, nerve grafting, neurostimulation and neuromodulation surgeries, and others. The direct nerve repair segment accounts for the largest revenue share due to improvements in surgical methods, rising public knowledge of this treatment option's advantages, and rising demand for reliable nerve repair methods.
Request for Customization –
Segmentation By End-User
Based on the end-user, the global peripheral nerve repair market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment accounts for the largest revenue share due to the rising patient pool, offering various services, including diagnosis, treatment, and rehabilitation.
Regional Growth Dynamics
Based on the region, the global peripheral nerve repair market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to the sophisticated healthcare infrastructure, adoption of advanced tools, and leading region in technology, North America accounts for the largest market revenue share.
Report Coverage
Growth Plus Reports studied the global market for peripheral nerve repair in-depth. Basic market features, revenue projections, important investment sectors, analyses of regional growth, rival market participants, and mergers and acquisitions were all examined.
Table of Content
INTRODUCTION Market Ecosystem Timeline Under Consideration Historical Years – 2021 Base Year – 2022 Forecast Years – 2023 to 2031 Currency Used in the Report RESEARCH METHODOLOGY Research Approach Data Collection Methodology Data Sources Secondary Sources Primary Sources Market Estimation Approach Bottom Up Top Down Market Forecasting Model Limitations and Assumptions PREMIUM INSIGHTS Current Market Trends (COVID-19 Perspective) Key Players & Competitive Positioning (2022) Regulatory Landscape Reimbursement Scenario MARKET DYNAMICS Drivers Restraints/Challenges Opportunities GLOBAL PERIPHERAL NERVE REPAIR MARKET - ANALYSIS & FORECAST, BY PRODUCT Neurostimulation and Neuromodulation Devices External Neurostimulation Device Transcranial Magnetic Stimulation (TMS) Transcutaneous Electrical Nerve Stimulation (TENS) Internal Neurostimulation Device Gastric Electrical Stimulation (GES) Vagus Nerve Stimulation (VNS) Sacral Nerve Stimulation (SNS) Spinal Cord Stimulation (SCS) Deep Brain Stimulation (DBS) Biomaterials Nerve Conduit Nerve Protector Nerve Connector Nerve Wraps GLOBAL PERIPHERAL NERVE REPAIR MARKET - ANALYSIS & FORECAST, BY APPLICATION Direct Nerve Repair Stem Cell Therapy Nerve Grafting Neurostimulation and Neuromodulation Surgeries Others GLOBAL PERIPHERAL NERVE REPAIR MARKET - ANALYSIS & FORECAST, BY END USER Hospitals Ambulatory Surgical Centers Othersperipheral nerve repair market toc
Buy this Premium Research Report:
VALUE PROPOSITIONS RELATED TO THE REPORT :
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report Comprehensive quantitative and qualitative insights at segment and sub-segment level Covid 19 impact trends and perspective Granular insights at global/regional/country level Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment Blanket coverage on competitive landscape Winning imperatives Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.
CUSTOMIZATION OPTIONS :
- Distributor Landscape Assessment Pricing Intelligence Customer Base Assessment Investment & Initiatives Analysis 'Business Profile' of Key Players
Schedule a call with our analyst:
Visit our report store at -
Browse more latest healthcare reports:
combination antihypertensives market by Type (ACE Inhibitors with Calcium Channel blocking agents, ACE inhibitors with thiazides), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
hydatid disease treatment market by Drug (Mebendazole, Albendazole), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
high-grade neuroendocrine neoplasms market by Drug Class (Platinum Coordination Complexes, Somatostatin Analogues), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
postoperative pain medication market by Drug Class (NSAIDS, Opioids), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
mast cell stabilizers market by Type (Mastocytosis, Seasonal Allergic Rhinitis, and Perennial Allergic Conjunctivitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook and Forecast 2023-2031
Unleashing the Power of Innovation in Med Tech:
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020".
Tags peripheral nerve repair Related Links
- hydatid disease treatment market combination antihypertensives market
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment